NGM Biopharmaceuticals saw the highest growth of 149% in patent filings in November and 24% in grants in October in Q4 2023. Compared to Q3 2023, Q4 2023 saw an increase in patent filings by 99% and grants by 24%. GlobalData’s DataBook provides a comprehensive analysis of NGM Biopharmaceuticals‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

NGM Biopharmaceuticals has been focused on protecting inventions in United States(US) with four publications in Q4 2023

The United States(US) Patent Office dominates the patent filings and grants with nearly 29% filings and 100% grants. The World Intellectual Property Organization(WIPO), United States(US), and Australia(AU) patent Office are among the top ten patent offices where NGM Biopharmaceuticals is filings its patents. Among the top granted patent authorities, NGM Biopharmaceuticals has 100% of its grants in United States(US)

Johnson & Johnson and Pfizer could be the strongest competitors for NGM Biopharmaceuticals

Patents related to rare diseases lead NGM Biopharmaceuticals's portfolio

NGM Biopharmaceuticals has the highest number of patents in rare diseases. For rare diseases, nearly 100% of patents were filed and 100% of patents were granted in Q4 2023.

Metabolic syndrome related patents lead NGM Biopharmaceuticals portfolio followed by diabetes, and hyperglycemia

NGM Biopharmaceuticals has highest number of patents in metabolic syndrome followed by diabetes, hyperglycemia, obesity, and breast cancer. For metabolic syndrome, nearly 5% of patents were filed and 4% of patents were granted in Q4 2023.

For comprehensive analysis of NGM Biopharmaceuticals's filings and grants, buy the databook here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.